Data from the open-label extension period of the APOLLO-B trial provide new insight into the benefits of patisiran in patients with ATTR amyloidosis with cardiomyopathy.
Entrepreneurial Culture, Strong Demand, New Acquisitions, Operating Efficiencies, and Technology Advancements Contributed to Record Results and Support Confidence in EVI’s Long-Term Growth. | May 10, 2023
(BPT) - At age 47, Jamie loves to exercise, running during the summer and going to the gym to work out during the winter. Between running and weightlifting, Jamie is
(BPT) - At age 47, Jamie loves to exercise, running during the summer and going to the gym to work out during the winter. Between running and weightlifting, Jamie is active, strong and energetic …